אינפנריקס הקסא

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); HAEMOPHILUS B; HEPATITIS B VACCINES; PERTACTIN; PERTUSSIS TOXOID (PT); POLIOVIRUS TYPE 1 INACTIVATED; POLIOVIRUS TYPE 2 INACTIVATED; POLIOVIRUS TYPE 3 INACTIVATED; TETANUS TOXOID

Disponible depuis:

GLAXO SMITH KLINE (ISRAEL) LTD

Code ATC:

J07CA

forme pharmaceutique:

אבקה ותרחיף להכנת תרחיף להזרקה

Composition:

FILAMENTOUS HAEMAGGLUTININ (FHA) 25 MCG/DOSE; DIPHTHERIA TOXOID NLT 30 IU/DOSE; TETANUS TOXOID NLT 40 IU/DOSE; HEPATITIS B VACCINES 10 MCG/DOSE; POLIOVIRUS TYPE 1 INACTIVATED 40 DU/DOSE; POLIOVIRUS TYPE 2 INACTIVATED 8 DU/DOSE; POLIOVIRUS TYPE 3 INACTIVATED 32 DU/DOSE; HAEMOPHILUS B 10 MCG/DOSE; PERTACTIN 8 MCG/DOSE; PERTUSSIS TOXOID (PT) 25 MCG/DOSE

Mode d'administration:

תוך-שרירי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

GLAXO SMITH KLINE BIOLOGICALS S.A

Groupe thérapeutique:

BACTERIAL AND VIRAL VACCINES, COMBINED

indications thérapeutiques:

Infantix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by haemophilus influenza type b.

Date de l'autorisation:

2020-07-31